Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Nov 29, 2004 3:16pm
282 Views
Post# 8243030

RE: Television coverage

RE: Television coverageViper... any press will help. We arent expecting to see the actual launch of the PRDT / MacoPharma product until well into 2005. I think the next major announcement in this regard is the CE Approval on the Bag/filter itself. The CE mark is a huge deal for us. Once that is "in the bag" then we're off to the races. Think about the worldwide publicity potential of announcing the first commercially available product capable of CJB Prion removal. The implications are truly enourmous. It'll be interesting to see how long it will take the market to figure out the magnitude of what's coming. We are only playing catch-up with this most recent move, we are still grossly undervalued.
Bullboard Posts